• 文献标题:   Synergistic antibacterial effects of localized heat and oxidative stress caused by hydroxyl radicals mediated by graphene/iron oxide-based nanocomposites
  • 文献类型:   Article
  • 作  者:   PAN WY, HUANG CC, LIN TT, HU HY, LIN WC, LI MJ, SUNG HW
  • 作者关键词:   photothermal therapy, fenton reaction, multipledrugresistant bacteria, oxidative stres, hyperthermia
  • 出版物名称:   NANOMEDICINENANOTECHNOLOGY BIOLOGY MEDICINE
  • ISSN:   1549-9634 EI 1549-9642
  • 通讯作者地址:   Natl Tsing Hua Univ
  • 被引频次:   30
  • DOI:   10.1016/j.nano.2015.11.014
  • 出版年:   2016

▎ 摘  要

This work develops a composite system of reduced graphene oxide (rGO)-iron oxide nanoparticles (rGO-IONP) that can synergistically induce physical and chemical damage to methicillin-resistant Staphylococcus aureus (MRSA) that are present in subcutaneous abscesses. rGO-IONP was synthesized by the chemical deposition of Fe-2(+)/Fe3+ ions on nanosheets of rGO in aqueous ammonia. The antibacterial efficacy of the as-prepared rGO-IONP was evaluated in a mouse model with MRSA-infected subcutaneous abscesses. Upon exposure to a near-infrared laser in vitro, rGO-IONP synergistically generated localized heat and large amounts of hydroxyl radicals, which inactivated MRSA. The in vivo results reveal that combined treatment with localized heat and oxidative stress that is caused by hydroxyl radicals accelerated the healing of wounds associated with MRSA-infected abscesses. The above results demonstrate that an rGO-IONP nanocomposite system that can effectively inactivate multiple-drug-resistant bacteria in subcutaneous infections was successfully developed. From the Clinical Editor: The emergence of methicillin-resistant S. aureus (MRSA) has posed a significant problem in the clinical setting. Thus, it is imperative to develop new treatment strategies against this. In this study, the authors described the use of reduced graphene oxide (rGO)-iron oxide nanoparticles (rGO-IONP) to induce heat and chemical damage to MRSA. This approach may provide a platform the design of other treatment modalities against multiple-drug-resistant bacteria. (c) 2015 Elsevier Inc. All rights reserved.